» Articles » PMID: 17363747

Thiazolidinedione Treatment Decreases Bone Mineral Density in Type 2 Diabetic Men

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2007 Mar 17
PMID 17363747
Citations 56
Authors
Affiliations
Soon will be listed here.
Citing Articles

Effect of Chiglitazar and Sitagliptin on Bone Mineral Density and Body Composition in Untreated Patients with Type 2 Diabetes.

Wang Y, Zhou Y, Zhou X, Su X, Xu X, Li H Diabetes Metab Syndr Obes. 2024; 16:4205-4214.

PMID: 38162801 PMC: 10757783. DOI: 10.2147/DMSO.S439479.


The Role of PPARs in Breast Cancer.

Zhao B, Xin Z, Ren P, Wu H Cells. 2023; 12(1).

PMID: 36611922 PMC: 9818187. DOI: 10.3390/cells12010130.


A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment.

Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y Front Endocrinol (Lausanne). 2023; 13:1052592.

PMID: 36589835 PMC: 9794857. DOI: 10.3389/fendo.2022.1052592.


Secondary Osteoporosis and Metabolic Bone Diseases.

Sobh M, Abdalbary M, Elnagar S, Nagy E, Elshabrawy N, Abdelsalam M J Clin Med. 2022; 11(9).

PMID: 35566509 PMC: 9102221. DOI: 10.3390/jcm11092382.


Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes.

Rathinavelu S, Guidry-Elizondo C, Banu J J Diabetes Res. 2018; 2018:6354787.

PMID: 30525054 PMC: 6247387. DOI: 10.1155/2018/6354787.